【瑞科生物-B(02179.HK)与印度Biological E公司就重组九价HPV疫苗REC603达成产品授权合作】智

智通财经
30 Jun
【瑞科生物-B(02179.HK)与印度Biological E公司就重组九价HPV疫苗REC603达成产品授权合作】智通财经APP讯,瑞科生物-B(02179.HK)公布,公司与印度知名生物制品公司Biological E(BE公司)近日就重组九价HPV疫苗REC603签署产品授权合作协议。该公司将向BE公司进行疫苗配制及分包装技术授权,并在适当时机进行原液生产技术授权。根据协议,BE公司被独家授权在印度以及由联合国儿童基金会(UNICEF)、泛美卫生组织(PAHO)主导的招标市场进行重组九价HPV疫苗的开发,生产及商业化。目前,公司已收到合作预付款,并将按照合作进度收取里程碑付款,以及基于一定比例年净销售额的特许权使用费。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10